MedPath
NMPA Approval

Rituximab Injection

国药准字SJ20160029

March 26, 2021

S20160029

Drug Information

利妥昔单抗注射液

美罗华

注射剂

100mg/10ml

生物制品

March 26, 2021

March 25, 2026

Company Information

Applicant Company

Grenzacherstrasse 124, 4058 Basel, Switzerland

Manufacturing Company

Sandhofer Strasse 116 68305 Mannheim Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利妥昔单抗注射液 - NMPA 批准文号 | MedPath